IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 193 filers reported holding IMMUNOGEN INC in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,850,077 | -44.3% | 116,577 | -33.8% | 1.17% | -41.7% |
| Q2 2023 | $3,321,875 | +242.5% | 176,040 | -30.3% | 2.01% | +202.6% |
| Q1 2023 | $969,800 | -29.8% | 252,552 | -9.4% | 0.66% | -30.3% |
| Q4 2022 | $1,381,990 | +21.3% | 278,627 | +16.9% | 0.95% | -18.1% |
| Q3 2022 | $1,139,000 | +6.7% | 238,302 | +0.5% | 1.16% | +66.4% |
| Q2 2022 | $1,067,000 | -1.1% | 237,202 | +4.7% | 0.70% | +37.0% |
| Q1 2022 | $1,079,000 | -29.6% | 226,602 | +9.7% | 0.51% | -23.6% |
| Q4 2021 | $1,533,000 | +42.5% | 206,652 | +8.9% | 0.67% | +31.2% |
| Q3 2021 | $1,076,000 | -17.1% | 189,702 | -3.7% | 0.51% | -15.1% |
| Q2 2021 | $1,298,000 | -16.6% | 197,002 | +1.7% | 0.60% | -23.0% |
| Q1 2021 | $1,557,000 | -0.4% | 193,755 | -20.7% | 0.78% | -8.2% |
| Q4 2020 | $1,564,000 | – | 244,421 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |